- Home
- SHAK vs GH Comparison
SHAK vs GH Comparison
Compare SHAK & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHAK
- GH
- Stock Information
- Founded
- SHAK 2004
- GH 2011
- Country
- SHAK United States
- GH United States
- Employees
- SHAK N/A
- GH N/A
- Industry
- SHAK Restaurants
- GH Medical Specialities
- Sector
- SHAK Consumer Discretionary
- GH Health Care
- Exchange
- SHAK Nasdaq
- GH Nasdaq
- Market Cap
- SHAK 3.9B
- GH 3.0B
- IPO Year
- SHAK 2015
- GH 2018
- Fundamental
- Price
- SHAK $97.09
- GH $25.81
- Analyst Decision
- SHAK Buy
- GH Strong Buy
- Analyst Count
- SHAK 19
- GH 17
- Target Price
- SHAK $107.58
- GH $39.31
- AVG Volume (30 Days)
- SHAK 847.5K
- GH 2.2M
- Earning Date
- SHAK 10-31-2024
- GH 11-04-2024
- Dividend Yield
- SHAK N/A
- GH N/A
- EPS Growth
- SHAK N/A
- GH N/A
- EPS
- SHAK 0.63
- GH N/A
- Revenue
- SHAK $1,169,450,000.00
- GH $643,810,000.00
- Revenue This Year
- SHAK $17.15
- GH $27.01
- Revenue Next Year
- SHAK $15.86
- GH $18.30
- P/E Ratio
- SHAK $153.58
- GH N/A
- Revenue Growth
- SHAK 17.96
- GH 26.20
- 52 Week Low
- SHAK $52.79
- GH $15.81
- 52 Week High
- SHAK $111.29
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- SHAK 46.89
- GH 43.49
- Support Level
- SHAK $92.66
- GH $23.48
- Resistance Level
- SHAK $100.19
- GH $26.85
- Average True Range (ATR)
- SHAK 3.73
- GH 1.15
- MACD
- SHAK -1.63
- GH -0.13
- Stochastic Oscillator
- SHAK 23.93
- GH 40.31
About SHAK Shake Shack Inc.
Shake Shack Inc is a roadside burger stand. It is serving a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.